GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan

Key TakeawaysGSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs.The British drugs giant said it expects 2031 revenue to be more than 40 billion pounds.GSK's fourth-quarter core earnings per share and revenue also beat estimates. GSK Plc's (GSK) U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a  stock ...